2023. Low levels of HER2 expression: new ideas for differentiated strategies in the choice of treatment for triple-negative breast cancers. Voprosy onkologii. 69, 1 (Mar. 2023), 38–44. DOI:https://doi.org/10.37469/0507-3758-2023-69-1-38-44.